<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38392595</PMID><DateRevised><Year>2024</Year><Month>02</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2075-4426</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Jan</Month><Day>31</Day></PubDate></JournalIssue><Title>Journal of personalized medicine</Title><ISOAbbreviation>J Pers Med</ISOAbbreviation></Journal><ArticleTitle>Reversibility of the Enlargement of the Pulmonary Artery in COVID-19 Pneumonia as a Marker of Remission of the Disease.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">161</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jpm14020161</ELocationID><Abstract><AbstractText>Coronavirus disease 2019 (COVID-19) pneumonia is associated with extensive pulmonary microangiopathy and the enlargement of the pulmonary artery (PA), while its progression after the remission of the disease has not been investigated yet. The aim was to assess the diametral increase in the PA in COVID-19 pneumonia, as revealed on chest computed tomography (CT), and further investigate its progression. This was a retrospective cohort study of patients with COVID-19 pneumonia, without prior history of pulmonary hypertension, who underwent CT pulmonary angiography before, during, and after the infection. Pulmonary embolism was excluded in all cases. The main PA diameter (MPAD) was assessed in consecutive chest imaging. Statistical analysis was performed with the non-parametric Wilcoxon and Kruskal-Wallis tests, while correlations were performed with the non-parametric Spearman test. A mean &#xb1; SD MPAD of 3.1 &#xb1; 0.3 cm in COVID-19 pneumonia was significantly decreased to 2.8 &#xb1; 0.3 cm in the post-infectious state after 2-18 months in 31 patients (<i>p</i>-value: &lt;0.0001). In a subgroup of six patients with more than one post-COVID-19 CT, a significant further decline in the diameter was observed (<i>p</i>-value: 0.0313). On the other hand, in accordance with the literature, a significant increase in the MPAD during COVID-19 pneumonia was noted in a group of 10 patients with a pre-COVID-19 CT (<i>p</i>-value: 0.0371). The enlargement of the PA is a common finding in COVID-19 pneumonia that regresses after the remission of the disease, indicating that this reversible cardiovascular event is a potential marker of disease activity, while its course in long COVID is yet to be determined.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Matthaiou</LastName><ForeName>Andreas M</ForeName><Initials>AM</Initials><Identifier Source="ORCID">0000-0003-1941-0213</Identifier><AffiliationInfo><Affiliation>Laboratory of Molecular and Cellular Pneumonology, Medical School, University of Crete, 71500 Heraklion, Greece.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Respiratory Medicine, University Hospital of Heraklion, 71500 Heraklion, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bizymi</LastName><ForeName>Nikoleta</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-5199-1519</Identifier><AffiliationInfo><Affiliation>Laboratory of Molecular and Cellular Pneumonology, Medical School, University of Crete, 71500 Heraklion, Greece.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Respiratory Medicine, University Hospital of Heraklion, 71500 Heraklion, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pagonidis</LastName><ForeName>Konstantinos</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Medical Imaging, Knossos Medical Diagnosis Centre, 71409 Heraklion, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manousaki</LastName><ForeName>Eirini</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Medical Imaging, Knossos Medical Diagnosis Centre, 71409 Heraklion, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fragkoulakis</LastName><ForeName>Michail</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medical Imaging, Knossos Medical Diagnosis Centre, 71409 Heraklion, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lambiri</LastName><ForeName>Irini</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, University Hospital of Heraklion, 71500 Heraklion, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mitrouska</LastName><ForeName>Ioanna</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, University Hospital of Heraklion, 71500 Heraklion, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vasarmidi</LastName><ForeName>Eirini</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-0747-0227</Identifier><AffiliationInfo><Affiliation>Laboratory of Molecular and Cellular Pneumonology, Medical School, University of Crete, 71500 Heraklion, Greece.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Respiratory Medicine, University Hospital of Heraklion, 71500 Heraklion, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tzanakis</LastName><ForeName>Nikolaos</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular and Cellular Pneumonology, Medical School, University of Crete, 71500 Heraklion, Greece.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Respiratory Medicine, University Hospital of Heraklion, 71500 Heraklion, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antoniou</LastName><ForeName>Katerina M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular and Cellular Pneumonology, Medical School, University of Crete, 71500 Heraklion, Greece.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Respiratory Medicine, University Hospital of Heraklion, 71500 Heraklion, Greece.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Pers Med</MedlineTA><NlmUniqueID>101602269</NlmUniqueID><ISSNLinking>2075-4426</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">chest imaging</Keyword><Keyword MajorTopicYN="N">pulmonary artery enlargement</Keyword><Keyword MajorTopicYN="N">pulmonary hypertension</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>1</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>1</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>23</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>23</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>23</Day><Hour>10</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38392595</ArticleId><ArticleId IdType="pmc">PMC10890114</ArticleId><ArticleId IdType="doi">10.3390/jpm14020161</ArticleId><ArticleId IdType="pii">jpm14020161</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lu H., Stratton C.W., Tang Y.W. Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle. J. Med. Virol. 2020;92:401&#x2013;402. doi: 10.1002/jmv.25678.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25678</ArticleId><ArticleId IdType="pmc">PMC7166628</ArticleId><ArticleId IdType="pubmed">31950516</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamers M.M., Haagmans B.L. SARS-CoV-2 pathogenesis. Nat. Rev. Microbiol. 2022;20:270&#x2013;284. doi: 10.1038/s41579-022-00713-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00713-0</ArticleId><ArticleId IdType="pubmed">35354968</ArticleId></ArticleIdList></Reference><Reference><Citation>Siddiqi H.K., Libby P., Ridker P.M. COVID-19&#x2014;A vascular disease. Trends Cardiovasc. Med. 2021;31:1&#x2013;5. doi: 10.1016/j.tcm.2020.10.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcm.2020.10.005</ArticleId><ArticleId IdType="pmc">PMC7556303</ArticleId><ArticleId IdType="pubmed">33068723</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh S., Zuwasti U., Haas C. Coronavirus-Associated Coagulopathy: Lessons From SARS-CoV1 and MERS-CoV for the Current SARS-CoV2 Pandemic. Cureus. 2020;12:e11310. doi: 10.7759/cureus.11310.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.11310</ArticleId><ArticleId IdType="pmc">PMC7714748</ArticleId><ArticleId IdType="pubmed">33282586</ArticleId></ArticleIdList></Reference><Reference><Citation>Niculae C.M., Anghel A.M.J., Militaru E.D., T&#xee;rlescu L.G., Lazar M., Hristea A. Acute Pulmonary Artery Thrombosis despite Anticoagulation in Patients with COVID-19 Pneumonia: A Single-Center Retrospective Cohort Study. J. Clin. Med. 2022;11:2633. doi: 10.3390/jcm11092633.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11092633</ArticleId><ArticleId IdType="pmc">PMC9100155</ArticleId><ArticleId IdType="pubmed">35566758</ArticleId></ArticleIdList></Reference><Reference><Citation>Barna N., Chapman J., Hutchins K., Garavan F. Atypical endovascular cells in SARS-CoV-2 pneumonia. Am. J. Forensic Med. Pathol. 2020;41:E61&#x2013;E63. doi: 10.1097/PAF.0000000000000626.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PAF.0000000000000626</ArticleId><ArticleId IdType="pubmed">32969849</ArticleId></ArticleIdList></Reference><Reference><Citation>Grosse C., Grosse A., Salzer H.J.F., D&#xfc;nser M.W., Motz R., Langer R. Analysis of cardiopulmonary findings in COVID-19 fatalities: High incidence of pulmonary artery thrombi and acute suppurative bronchopneumonia. Cardiovasc. Pathol. 2020;49:107263. doi: 10.1016/j.carpath.2020.107263.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.carpath.2020.107263</ArticleId><ArticleId IdType="pmc">PMC7365076</ArticleId><ArticleId IdType="pubmed">32784110</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson N.R., Zeigler K., Torrez M., Makino Y., Adolphi N.L., Lathrop S., Decker L., Dvorscak L., Proe L., Paul I.D., et al. New Mexico&#x2019;s COVID-19 Experience. Am. J. Forensic Med. Pathol. 2021;42:1&#x2013;8. doi: 10.1097/PAF.0000000000000664.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PAF.0000000000000664</ArticleId><ArticleId IdType="pmc">PMC7870043</ArticleId><ArticleId IdType="pubmed">33416234</ArticleId></ArticleIdList></Reference><Reference><Citation>Keane G., Dorman T. Fatal pulmonary thromboembolism in asymptomatic COVID-19. Ir. J. Med. Sci. 2022;191:1777&#x2013;1783. doi: 10.1007/s11845-021-02735-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11845-021-02735-8</ArticleId><ArticleId IdType="pmc">PMC8418686</ArticleId><ArticleId IdType="pubmed">34482482</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrade B.S., Siqueira S., de Assis Soares W.R., de Souza Rangel F., Santos N.O., Dos Santos Freitas A., da Silveira P.R., Tiwari S., Alzahrani K.J., G&#xf3;es-Neto A., et al. Long-covid and post-covid health complications: An up-to-date review on clinical conditions and their possible molecular mechanisms. Viruses. 2021;13:700. doi: 10.3390/v13040700.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13040700</ArticleId><ArticleId IdType="pmc">PMC8072585</ArticleId><ArticleId IdType="pubmed">33919537</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng J.-H., Wu W.-B., Qu J.-X., Wang Y., Dong C.-F., Luo Y.-F., Zhou D., Feng W.-X., Feng C. Cardiac manifestations of COVID-19 in Shenzhen, China. Infection. 2020;48:861&#x2013;870. doi: 10.1007/s15010-020-01473-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-020-01473-w</ArticleId><ArticleId IdType="pmc">PMC7386384</ArticleId><ArticleId IdType="pubmed">32725595</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Z., Huang Y., Lu W., Chen X., Li X., Zhang S., Su Z. Noninvasive assessment of cardiac changes in patients with coronavirus disease-19 (COVID-19) by bedside ultrasound. J. Thorac. Dis. 2022;14:423&#x2013;430. doi: 10.21037/jtd-21-1961.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/jtd-21-1961</ArticleId><ArticleId IdType="pmc">PMC8902119</ArticleId><ArticleId IdType="pubmed">35280482</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Li H., Zhu S., Xie Y., Wang B., He L., Zhang D., Zhang Y., Yuan H., Wu C., et al. Prognostic Value of Right Ventricular Longitudinal Strain in Patients With COVID-19. JACC Cardiovasc. Imaging. 2020;13:2287&#x2013;2299. doi: 10.1016/j.jcmg.2020.04.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2020.04.014</ArticleId><ArticleId IdType="pmc">PMC7195441</ArticleId><ArticleId IdType="pubmed">32654963</ArticleId></ArticleIdList></Reference><Reference><Citation>Besutti G., Monelli F., Schir&#xf2; S., Milone F., Ottone M., Spaggiari L., Facciolongo N., Salvarani C., Croci S., Pattacini P., et al. Follow-Up CT Patterns of Residual Lung Abnormalities in Severe COVID-19 Pneumonia Survivors: A Multicenter Retrospective Study. Tomography. 2022;8:1184&#x2013;1195. doi: 10.3390/tomography8030097.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/tomography8030097</ArticleId><ArticleId IdType="pmc">PMC9149852</ArticleId><ArticleId IdType="pubmed">35645383</ArticleId></ArticleIdList></Reference><Reference><Citation>Bao C., Liu X., Zhang H., Li Y., Liu J. Coronavirus Disease 2019 (COVID-19) CT Findings: A Systematic Review and Meta-analysis. J. Am. Coll. Radiol. 2020;17:701&#x2013;709. doi: 10.1016/j.jacr.2020.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacr.2020.03.006</ArticleId><ArticleId IdType="pmc">PMC7151282</ArticleId><ArticleId IdType="pubmed">32283052</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva M., Ledda R.E., Schiebler M., Balbi M., Sironi S., Milone F. Frequency and characterization of ancillary chest CT findings in COVID-19 pneumonia. Br. J. Radiol. 2021;94:20200716. doi: 10.1259/bjr.20200716.</Citation><ArticleIdList><ArticleId IdType="doi">10.1259/bjr.20200716</ArticleId><ArticleId IdType="pmc">PMC7934290</ArticleId><ArticleId IdType="pubmed">33471553</ArticleId></ArticleIdList></Reference><Reference><Citation>Spagnolo P., Cozzi A., Fo&#xe0; R.A., Spinazzola A., Monfardini L., Bn&#xe0; C., Al&#xec; M., Schiaffino S., Sardanelli F. CT-derived pulmonary vascular metrics and clinical outcome in COVID-19 patients. Quant. Imaging Med. Surg. 2020;10:1325&#x2013;1333. doi: 10.21037/qims-20-546.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/qims-20-546</ArticleId><ArticleId IdType="pmc">PMC7276354</ArticleId><ArticleId IdType="pubmed">32550141</ArticleId></ArticleIdList></Reference><Reference><Citation>Truong Q.A., Bhatia H.S., Szymonifka J., Zhou Q., Lavender Z., Waxman A.B., Semigran M.J., Malhotra R. A four-tier classification system of pulmonary artery metrics on computed tomography for the diagnosis and prognosis of pulmonary hypertension. J. Cardiovasc. Comput. Tomogr. 2018;12:60&#x2013;66. doi: 10.1016/j.jcct.2017.12.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcct.2017.12.001</ArticleId><ArticleId IdType="pmc">PMC6934139</ArticleId><ArticleId IdType="pubmed">29254655</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer T., El Baz Y., Graf N., Wildermuth S., Leschka S., Kleger G.-R., Pietsch U., Frischknecht M., Scanferla G., Strahm C., et al. Clinical and Imaging Features of COVID-19-Associated Pulmonary Aspergillosis. Diagnostics. 2022;12:1201. doi: 10.3390/diagnostics12051201.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics12051201</ArticleId><ArticleId IdType="pmc">PMC9140144</ArticleId><ArticleId IdType="pubmed">35626356</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee I., Kim J., Yeo Y., Lee J.Y., Jeong I., Joh J.-S., Kim G., Chin B.S., Kim Y., Kim M.-K., et al. Prognostic Factors for Pulmonary Fibrosis Following Pneumonia in Patients with COVID-19: A Prospective Study. J. Clin. Med. 2022;11:5913. doi: 10.3390/jcm11195913.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11195913</ArticleId><ArticleId IdType="pmc">PMC9573655</ArticleId><ArticleId IdType="pubmed">36233779</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombi D., Petrini M., Risoli C., Mangia A., Milanese G., Silva M., Franco C., Sverzellati N., Michieletti E. Quantitative CT at Follow-Up of COVID-19 Pneumonia: Relationship with Pulmonary Function Tests. Diagnostics. 2023;13:3328. doi: 10.3390/diagnostics13213328.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics13213328</ArticleId><ArticleId IdType="pmc">PMC10648873</ArticleId><ArticleId IdType="pubmed">37958224</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavallari Strozze Catharin V.M., Zutin T.L.M., Guiguer E.L., Cressoni Ara&#xfa;jo A., Fornari Laurindo L., Chagas E.F.B., Gasparotti Zorzetto C.F., Bueno P.C.d.S., dos Santos Bueno M., Cervelim Nunes Y., et al. Radiological and Functional Pulmonary Evolution in Post-COVID-19 Patients: An Observational Study. Diseases. 2023;11:113. doi: 10.3390/diseases11030113.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diseases11030113</ArticleId><ArticleId IdType="pmc">PMC10528437</ArticleId><ArticleId IdType="pubmed">37754309</ArticleId></ArticleIdList></Reference><Reference><Citation>Esposito A., Palmisano A., Toselli M., Vignale D., Cereda A., Rancoita P.M.V., Leone R., Nicoletti V., Gnasso C., Monello A., et al. Chest CT&#x2013;derived pulmonary artery enlargement at the admission predicts overall survival in COVID-19 patients: Insight from 1461 consecutive patients in Italy. Eur. Radiol. 2021;31:4031&#x2013;4041. doi: 10.1007/s00330-020-07622-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00330-020-07622-x</ArticleId><ArticleId IdType="pmc">PMC7755582</ArticleId><ArticleId IdType="pubmed">33355697</ArticleId></ArticleIdList></Reference><Reference><Citation>Erdo&#x11f;an M., &#xd6;zt&#xfc;rk S., Erd&#xf6;l M.A., Kasapkara A., Be&#x15f;ler M.S., Kayaaslan B., Hasano&#x11f;lu &#x130;., Durmaz T., G&#xfc;ner R. Prognostic utility of pulmonary artery and ascending aorta diameters derived from computed tomography in COVID-19 patients. Echocardiography. 2021;38:1543&#x2013;1551. doi: 10.1111/echo.15170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/echo.15170</ArticleId><ArticleId IdType="pmc">PMC8444889</ArticleId><ArticleId IdType="pubmed">34355824</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Q.-Q., Gong T., Huang G.-Q., Niu Z.-F., Yue T., Xu F.-Y., Chen C., Wang G.-B. Pulmonary artery trunk enlargement on admission as a predictor of mortality in in-hospital patients with COVID-19. Jpn. J. Radiol. 2021;39:589&#x2013;597. doi: 10.1007/s11604-021-01094-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11604-021-01094-9</ArticleId><ArticleId IdType="pmc">PMC7982766</ArticleId><ArticleId IdType="pubmed">33751417</ArticleId></ArticleIdList></Reference><Reference><Citation>Lozano-Carrillo L.C., Hern&#xe1;ndez-Garate Y.A.K., Quiroga-Garza A., Elizondo-Oma&#xf1;a R.E., Guzman-Lopez S. Letter to the Editor concerning: Pulmonary artery trunk enlargement on admission as a predictor of mortality in in-hospital patients with COVID-19. Jpn. J. Radiol. 2022;40:334&#x2013;335. doi: 10.1007/s11604-021-01170-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11604-021-01170-0</ArticleId><ArticleId IdType="pmc">PMC8280626</ArticleId><ArticleId IdType="pubmed">34264419</ArticleId></ArticleIdList></Reference><Reference><Citation>Yildiz M., Yadigar S., Yildiz B.&#x15e;., Aladag N.B., Keskin O., Ozer R.S., Topel C., Kahraman S. Evaluation of the relationship between COVID-19 pneumonia severity and pulmonary artery diameter measurement. Herz. 2021;46:56&#x2013;62. doi: 10.1007/s00059-020-05014-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00059-020-05014-x</ArticleId><ArticleId IdType="pmc">PMC7802061</ArticleId><ArticleId IdType="pubmed">33433652</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q., Huang X.T., Li C.H., Liu D., Lv F.J. CT features of coronavirus disease 2019 (COVID-19) with an emphasis on the vascular enlargement pattern. Eur. J. Radiol. 2021;134:109442. doi: 10.1016/j.ejrad.2020.109442.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejrad.2020.109442</ArticleId><ArticleId IdType="pmc">PMC7694475</ArticleId><ArticleId IdType="pubmed">33321459</ArticleId></ArticleIdList></Reference><Reference><Citation>Jalde F.C., Beckman M.O., Svensson A.M., Bell M., Sk&#xf6;ld M., Strand F., Nyren S., Kistner A. Widespread Parenchymal Abnormalities and Pulmonary Embolism on Contrast-Enhanced CT Predict Disease Severity and Mortality in Hospitalized COVID-19 Patients. Front. Med. 2021;8:666723. doi: 10.3389/fmed.2021.666723.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.666723</ArticleId><ArticleId IdType="pmc">PMC8275973</ArticleId><ArticleId IdType="pubmed">34268322</ArticleId></ArticleIdList></Reference><Reference><Citation>Riachy M.A., Ismail A., Awali M., Farah F., Haddad S.F., Kerbage A., Aoun N., Sleilaty G. Pulmonary Artery Enlargement: An Independent Risk Factor for Mortality in Patients Hospitalized With COVID-19. Mayo Clin. Proc. Innov. Qual. Outcomes. 2022;6:399&#x2013;408. doi: 10.1016/j.mayocpiqo.2022.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocpiqo.2022.07.001</ArticleId><ArticleId IdType="pmc">PMC9300717</ArticleId><ArticleId IdType="pubmed">35880237</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>